PatchAi and Roche Italia launch virtual platform for oncology patients

Posted on

Italian startup PatchAi has joined forces with pharma massive Roche to launch a digital reply for victims affected by oncological sicknesses.

PatchAi for Good Well being Companion (SHC) embeds a digital assistant which engages victims by empathic conversations using artificial intelligence (AI) and machine learning.

Following a pilot of the platform in July last 12 months, it is now on the market to all non-public and non-private avid gamers throughout the effectively being sector.

HIMSS20 Digital

Study on-demand, earn credit score rating, uncover merchandise and choices. Get Began >>

SHC delivers the Roche affected individual help programme for victims with haemato-oncological conditions in Italy.

The reply objectives to reinforce self-management of effectively being conditions with choices resembling monitoring and sharing every day diaries, managing adherence and producing precise world proof by the use of conversational reported outcomes (Co-PRO®). Insights are collected and analysed to reinforce victims’ experience, clinicians’ workflows and help care provide. 


PatchAI and Roche hope to drive digital transformation of healthcare in Italy, paving one of the simplest ways in facilitating effectively being system sustainability and optimising healthcare provide by ensuring affected individual engagement. 

In the course of the COVID-19 pandemic, the Italian Affiliation of Medical Oncology (AIOM) reported a 30% drop in first visits for evaluation and a 36% drop in bodily visits.

With the adoption of SHC, healthcare professionals may also help their victims in precise time by video-consultations and purchase effectively being info.

Preliminary info on victims enrolled in Medical Analysis using PatchAi platform reveals a protocol adherence of as a lot as 95%, which is as a lot as 9 events larger than paper-based choices.


Earlier this 12 months PatchAi closed a €1.7 million spherical, will allow the company to broaden its enterprise to completely different therapeutic areas and scale internationally. In line with a modern report by Dealroom, it is definitely one in every of solely 5 Italian startups throughout the effectively being tech enterprise to elevate €5.2 million in funding collectively.

In the meantime, Roche not too way back added distant monitoring to its diabetes care platform, which allows medical docs to enrol victims and personalise the experience.


Elia Ganzi, built-in purchaser administration director at Roche Italia, talked about: “Along with many non-public and non-private companions throughout the effectively being ecosystem, we envisioned a solution enabling important enhancements in oncology and haematology care pathways. Our efforts led to SHC, the first digital effectively being reply registered as a medical gadget and completely personalised for oncology and haematology victims in Italy.

“The proof collected present the capability to consolidate extra experiential and medical worth for the affected person with a optimistic contribution to the healthcare system sustainability.”

Alessandro Monterosso, PatchAi CEO and cofounder, talked about: “With this main achievement, we’ll work in direction of taking part in an energetic function in redefining and revolutionising affected person engagement inside digital healthcare. To allow the transformation of the present well being techniques, we will likely be serving to medical groups in quickly and effectively supporting sufferers and translate ‘affected person centricity’ into programmes that display their reliability and effectiveness from a health-economic perspective primarily based on information pushed outcomes.” 

Leave a Reply

Your email address will not be published. Required fields are marked *